Neuspera Medical has announced FDA clearance of its Neuspera ultra-miniaturized neurostimulation therapy system, according to a company press release.
The Neuspera ultra-miniaturized system utilizes a wireless platform and wearable device to provide peripheral nerve stimulation for patients with chronic pain.
“We look forward to bringing this innovative technology to physicians and patients in the U.S.,” Steffen Hovard, CEO of Neuspera Medical, said in the release. “The Neuspera ultra-miniaturized system has the potential to revolutionize the way physicians treat patients